1)Sun BY, Lee YH, Jiaan BP, et al:Recurrence rate and risk factors for urinary calculi after extracorporeal shock wave lithotripsy. J Urol 156:903-905, 1996
2)Carr LK, D'A Honey J, Jewett MA, et al:New stone formation:A comparison of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy. J Urol 155:1565-1567, 1996
3)日本泌尿器科学会,日本Endourology・ESWL学会,日本尿路結石症学会(編):尿路結石症診療ガイドライン.金原出版,2002
4)小川由英:結石に関する代謝系の検査法.臨泌 45:47-49,1991
5)Pak CYC, Britton F, Peterson R, et al:Ambulatory evaluation of nephlolithiasis. Am J Med 69:19-30, 1980
6)Pak CYC, Resnick MI:Medical therapy and new approaches to management of urolithiasis. Urol Clin North Am 27:243-253, 2000
7)八木澤 隆:尿路結石の成因評価とその意義.泌尿器外科 16:1141-1146,2003
8)Ohkawa T, Ebisuno S, Kitagawa M, et al:Rice bran treatment for patients with hypercalciuric stones:Experimental and clinical studies. J Urol 132:1140-1145, 1984
9)宮澤克人,鈴木孝治:尿路結石再発予防の薬物療法.泌尿器外科 16:1157-1163,2003
10)Laerum E, Larsen S:Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 215:383-389, 1984
11)Pearle MS, Roehrborn CG, Pak CYC:Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13:679-685, 1999
12)Yendt ER, Cohanim M:Prevention of calcium stones with thiazides. Kidney Int 13:397-409, 1978
13)Heyburn PJ, Robertson WG, Peacock M:Phosphate treatment of recurrent calcium stone disease. Nephron 32:314-319, 1982
14)Monico CG, Rossetti S, Olson JB, et al:Pyridoxine effect in typeⅠ primary hyperoxaluria is associated with the most common mutant allele. Kidney Int 67:1704-1709, 2005
. J Urol 166:1487-1491, 2001
16)Pak CYC:Citrate and renal calculi:New insights and future directions. Am J Kidney Dis 17:420-425, 1991
17)Hamm LL, Hering-Smith KS:Pathophysiology of hypocitraturic nephrolithiasis. Endocrinol Metab Clin North Am 31:885-893, 2002
18)Ogawa Y, Yamaguchi K, Morozumi M:Effects of magnesium salts in preventing experimental oxalate urolithiasis in rats. J Urol 144:385-389, 1990
19)Johansson G, Backman U, Danielson BG, et al:Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 124:770-774, 1980
20)Yoshida O, Terai A, Ohkawa T, et al:National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 56:1899-1904, 1999
21)Maalouf NM, Cameron MA, Moe OW, et al:Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 13:181-189, 2004
22)Mizoguchi K, Cha SH, Chairoungdua A, et al:Human cystinuria-related transporter:localization and functional characterization. Kidney Int 59:1821-1833, 2001
22)Beck EM, Riehle RA Jr:The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones. J Urol 145:6-10, 1991
23)奴田原紀久雄,東原英二:珊瑚状結石治療後の再発と増大.泌尿器外科 16:1153-1156,2003